01-10-2004 | Original Research Paper
Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis
Published in: Inflammation Research | Issue 10/2004
Login to get access